NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $33.23, above its previous 52-week high of $33.19 with 1.1 million shares traded as of 9:35 a.m. ET. Average volume has been 1.4 million shares over the past 30 days.
Lincare has a market cap of $2.69 billion and is part of the
industry. Shares are up 25.6% year to date as of the close of trading on Thursday.
Lincare Holdings Inc. provides oxygen, respiratory, and other chronic therapy services to patients in the home. The company has a P/E ratio of 15.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
TheStreet Ratings rates Lincare as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our